DNS - Denosumab
Economic Operator with Whom the Contract Has Been Concluded
| Show detail | ||||||||
|---|---|---|---|---|---|---|---|---|
| D 1675/2022-ÚVN | 14. 12. 2022 | Amgen s.r.o. | 2 414 297,16 | 2 194 815,60 | 2 414 297,16 | 2 194 815,60 | CZK |
Published Documents
List of Participants
| Show detail | ||||||
|---|---|---|---|---|---|---|
| Amgen s.r.o. | Praha |
Price Actually Paid in Each Year of Performance
| D 1675/2022-ÚVN | 2023 | 518 908,80 | 471 735,20 |
| D 1675/2022-ÚVN | 2022 | 40 238,28 | 36 580,26 |